Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes

PNEUMOVAX™ 23, a 23-valent polysaccharide pneumococcal vaccine (PPV23), covers 65% to 91% of the isolates recovered from adult cases of invasive pneumococcal disease. Several studies have demonstrated that pneumococcal serotypes 31, 11A, 35F, 17F, 3, 16F, 19F, 15B, and 10A are associated with higher...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Hum Vaccin Immunother
Main Authors: Ciprero, Karen L., Marchese, Rocio D., Richard, Patrick, Baudin, Martine, Sterling, Tina M., Manoff, Susan B., Radley, David, Stek, Jon E., Soubeyrand, Benoît, Grabenstein, John D., Samson, Sandrine I., Musey, Luwy K.
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis 2016
Fag:
Research Papers
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4994760/
https://ncbi.nlm.nih.gov/pubmed/27002793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1156270
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker